• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者的色觉缺陷和痰液颜色图表:一项探索性混合方法研究。

Colour vision deficiency and sputum colour charts in COPD patients: an exploratory mixed-method study.

机构信息

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

School of Social Policy, Health Service Management Centre, University of Birmingham, Birmingham, UK.

出版信息

NPJ Prim Care Respir Med. 2021 Mar 4;31(1):13. doi: 10.1038/s41533-021-00225-z.

DOI:10.1038/s41533-021-00225-z
PMID:33664262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7933280/
Abstract

Sputum colour may mark bacterial involvement in acute exacerbations of chronic obstructive pulmonary disease (COPD). However, whether colour vision deficiency (CVD) in COPD patients could impact the use of sputum colour charts as part of a guide to antibiotic use in exacerbations is unknown. This study used an exploratory mixed-method approach to establish the likelihood that COPD patients will be colour blind and whether this would result in the sputum colour chart being unusable in the context of the patients' self-management of their condition. CVD is under-reported in primary care and comorbidities in COPD patients increase the risk of acquiring CVD. Participants diagnosed with CVD and risk of acquiring CVD were able to use the sputum colour charts. Colour charts are likely to be usable even in the context of undiagnosed CVD in COPD patients.

摘要

痰的颜色可能标志着慢性阻塞性肺疾病(COPD)急性加重期的细菌感染。然而,COPD 患者的色觉缺陷(CVD)是否会影响痰色图表在加重期抗生素使用指南中的使用,目前尚不清楚。本研究采用探索性混合方法来确定 COPD 患者是否可能患有色盲,以及这是否会导致痰色图表在患者自我管理病情时无法使用。CVD 在初级保健中报告不足,COPD 患者的合并症增加了获得 CVD 的风险。患有 CVD 和有 CVD 风险的患者能够使用痰色图表。即使在 COPD 患者未诊断出 CVD 的情况下,色标图表也可能是可用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c2/7933280/76a3d998b844/41533_2021_225_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c2/7933280/76a3d998b844/41533_2021_225_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c2/7933280/76a3d998b844/41533_2021_225_Fig1_HTML.jpg

相似文献

1
Colour vision deficiency and sputum colour charts in COPD patients: an exploratory mixed-method study.慢性阻塞性肺疾病患者的色觉缺陷和痰液颜色图表:一项探索性混合方法研究。
NPJ Prim Care Respir Med. 2021 Mar 4;31(1):13. doi: 10.1038/s41533-021-00225-z.
2
Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease.患者报告的痰液颜色不能可靠地指示慢性阻塞性肺疾病急性加重期细菌的存在。
Clin Microbiol Infect. 2010 Jun;16(6):583-8. doi: 10.1111/j.1469-0691.2009.02892.x. Epub 2009 Jul 20.
3
Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease.痰的颜色是慢性阻塞性肺疾病细菌定植的标志物。
Respir Res. 2010 May 14;11(1):58. doi: 10.1186/1465-9921-11-58.
4
Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.ELOM-080对慢性支气管炎表型慢性阻塞性肺疾病患者急性加重和症状的影响——一项随机、双盲、安慰剂对照临床试验的事后分析
Int J Chron Obstruct Pulmon Dis. 2016 Nov 23;11:2877-2884. doi: 10.2147/COPD.S117652. eCollection 2016.
5
Sputum colour as a marker for bacteria in acute exacerbations of COPD: protocol for a systematic review and meta-analysis.痰液颜色作为 COPD 急性加重期细菌标志物的研究:系统评价和荟萃分析方案。
Syst Rev. 2021 Jul 27;10(1):211. doi: 10.1186/s13643-021-01767-6.
6
Relation of sputum colour to bacterial load in acute exacerbations of COPD.痰色与 COPD 急性加重期细菌负荷的关系。
Respir Med. 2009 Apr;103(4):601-6. doi: 10.1016/j.rmed.2008.10.012. Epub 2008 Nov 22.
7
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.贝那鲁肽治疗慢性阻塞性肺疾病和痰嗜酸性粒细胞增多症:一项随机、双盲、安慰剂对照、2a 期研究。
Lancet Respir Med. 2014 Nov;2(11):891-901. doi: 10.1016/S2213-2600(14)70187-0. Epub 2014 Sep 7.
8
Cough and sputum production as risk factors for poor outcomes in patients with COPD.咳嗽和咳痰是 COPD 患者不良结局的危险因素。
Respir Med. 2011 Aug;105(8):1118-28. doi: 10.1016/j.rmed.2011.02.003. Epub 2011 Feb 25.
9
Clinical Features and C-Reactive Protein as Predictors of Bacterial Exacerbations of COPD.慢性阻塞性肺疾病细菌恶化的临床特征和 C 反应蛋白预测。
Int J Chron Obstruct Pulmon Dis. 2020 Dec 1;15:3147-3158. doi: 10.2147/COPD.S265674. eCollection 2020.
10
Coloured filters can simulate colour deficiency in normal vision but cannot compensate for congenital colour vision deficiency.彩色滤光片可以模拟正常视觉中的色觉缺陷,但无法补偿先天性色觉缺陷。
Sci Rep. 2022 Jul 1;12(1):11140. doi: 10.1038/s41598-022-13877-9.

引用本文的文献

1
"I know this is on my chest, let's act": a qualitative study exploring self-management of acute COPD exacerbations with a sputum colour chart to reduce unnecessary antibiotic use.“我知道这在我的胸口,让我们行动起来”:一项使用痰液颜色图表来减少不必要抗生素使用的探索性 COPD 急性加重自我管理的定性研究。
NPJ Prim Care Respir Med. 2024 Nov 30;34(1):41. doi: 10.1038/s41533-024-00398-3.
2
Chlamydia psittaci Pneumonia: Diagnosis, Treatment, and Challenges in the Context of COVID-19.鹦鹉热衣原体肺炎:在 COVID-19 背景下的诊断、治疗和挑战。
Am J Case Rep. 2024 May 8;25:e942921. doi: 10.12659/AJCR.942921.

本文引用的文献

1
Sputum colour can identify patients with neutrophilic inflammation in asthma.痰液颜色可识别哮喘中性粒细胞炎症患者。
BMJ Open Respir Res. 2017 Oct 9;4(1):e000236. doi: 10.1136/bmjresp-2017-000236. eCollection 2017.
2
Comparison of color discrimination in chronic heavy smokers and healthy subjects.慢性重度吸烟者与健康受试者颜色辨别能力的比较。
F1000Res. 2017 Jan 27;6:85. doi: 10.12688/f1000research.10714.3. eCollection 2017.
3
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
全球、地区和国家慢性阻塞性肺疾病和哮喘的死亡、患病率、残疾调整生命年以及与残疾相关的生命年,1990-2015 年:2015 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2017 Sep;5(9):691-706. doi: 10.1016/S2213-2600(17)30293-X. Epub 2017 Aug 16.
4
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
5
Features of self-management interventions for people with COPD associated with improved health-related quality of life and reduced emergency department visits: a systematic review and meta-analysis.慢性阻塞性肺疾病患者自我管理干预措施与健康相关生活质量改善及急诊就诊次数减少相关的特征:一项系统评价和荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2017 Jun 8;12:1705-1720. doi: 10.2147/COPD.S133317. eCollection 2017.
6
Factors associated with impaired color vision without retinopathy amongst people with type 2 diabetes mellitus: a cross-sectional study.2型糖尿病患者中无视网膜病变的色觉受损相关因素:一项横断面研究。
BMC Endocr Disord. 2017 Jun 2;17(1):29. doi: 10.1186/s12902-017-0181-7.
7
Acquired color vision deficiency.获得性色觉障碍。
Surv Ophthalmol. 2016 Mar-Apr;61(2):132-55. doi: 10.1016/j.survophthal.2015.11.004. Epub 2015 Nov 30.
8
Self management for patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的自我管理
Cochrane Database Syst Rev. 2014 Mar 19;2014(3):CD002990. doi: 10.1002/14651858.CD002990.pub3.
9
Using the framework method for the analysis of qualitative data in multi-disciplinary health research.运用多学科健康研究中定性数据分析的框架方法。
BMC Med Res Methodol. 2013 Sep 18;13:117. doi: 10.1186/1471-2288-13-117.
10
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率:全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.